Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Frunevetmab injections in cats can cause severe itching and skin lesions.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.